Tag:Goodbody Health

European Cannabis Stocks Review: InterCure Up 10% Amid More Record Results, Stenocare Secures New Funding, & More From Goodbody Health

InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.  The Israeli cannabis giant reported another...

Goodbody Health Announces 1:10 Share Consolidation As It Completes Redomiciliation To Guernsey

GOODBODY Health informed investors this week that it intends to apply a 1:10 ‘reverse stock split’ as it waits for its shares to return...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress on cannabis liberalisation. Germany's...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read